ONVO has performed its first 3D Liver tissue delivery and also introduced updated guidance on the timing of its product launch. Organovo had planned to launch its 3D Liver tissue product by the end of December, but now expects to commence the commercial launch and start generating revenue through a services model prior to 12/14. ONVO anticipates that preclinical toxicology testing services can command prices in the high tens of thousands of dollars per compound for standard screening for liver alone. ONVO is UP as usual on large volume whether it is positive and negative but, it is still under 1/2/14’s $11.29. Great trading platform as traders “inhale and exhale once the high kicks-in”. Let ONVO run for a few days and then SELL on this news!